FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Janssen Pharmaceuticals Ortho-Novum 1/35 Recall

Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0

Janssen Pharmaceuticals, Inc. · Titusville, NJ

Risk level
Class II
Reported by FDA
Nov 14, 2018
Recall ID
D-0217-2019
Check your lot numberHow we source this data

Summary

Janssen Pharmaceuticals recalled Ortho-Novum 1/35 starting Oct 23, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0217-2019 on Nov 14, 2018. Reason: Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser. Status: Terminated.

Why it was recalled

Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.

Product description

Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28-Day Regimen per pouch (NDC 50458-176-28), 6 Veridate Tablet Dispensers and 6 refills per carton (NDC 50458-176-06), Rx only, Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674; Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560.

Lot numbers, UPCs & expiration codes

Lot # 18BM114, Exp. 03/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0217-2019
Classification
Class II
Status
Terminated
Recall initiated
Oct 23, 2018
FDA report date
Nov 14, 2018
Quantity
1,777 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Janssen Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0217-2019, exactly as published.

Show all FDA fields
City
Titusville
State
NJ
Status
Terminated
Country
United States
Event ID
81289
Address
1125 Trenton-Harbourton Rd.
Code information
Lot # 18BM114, Exp. 03/2020
Postal code
08560
Report date
Nov 14, 2018
Product type
Drugs
Recall number
D-0217-2019
Classification
Class II
Recalling firm
Janssen Pharmaceuticals, Inc.
Product quantity
1,777 cartons
Termination date
Oct 30, 2019
Reason for recall
Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28-Day Regimen per pouch (NDC 50458-176-28), 6 Veridate Tablet Dispensers and 6 refills per carton (NDC 50458-176-06), Rx only, Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674; Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560.
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 23, 2018
Initial firm notification
Letter
Center classification date
Nov 6, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0217-2019, published Nov 14, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls